• New TopSeal-A PLUS allows you to view wells throughout incubation process - no visibility effects with humidity
• Improved perforated end tabs allow easy handling, accurate positioning and quick removal of tabs after sealing
• Improved gluing strength
• Compatible with microplates used with Revvity reagent technologies (AlphaLISA™, AlphaScreen®, AlphaScreen® SureFire®, ATPlite™, Britelite™Plus, DELFIA®, LANCE®, LANCE® Ultra, Neolite™, Steadylite Plus®) and Revvity's detection instrumentation (EnSpire®, EnVision®, Victor®, ViewLux™)
• Compatible with microplates used radioisotopic assays (Filter binding, FlashPlate®, SPA) on Revvity TopCount™ and MicroBeta™ Scintillation and Luminescence counters

This product replaces product numbers 6050184, 6050195, 6005250, and 6005185.

At Revvity, we regard "impossibility" as inspiration and "inability" as the driving force. Revvity offers health science solutions, cutting - edge technologies and professional services, with its business covering the entire end - to - end process of scientific research exploration, development, diagnosis, and treatment. Relying on years of in - depth cultivation in fields such as translational multi - omics technology, biomarker identification, imaging, disease prediction, screening, detection and diagnosis, and informatics, Revvity is using the power of technology to break through the boundaries of human potential.

In 2023, Revvity's turnover exceeded $2.7 billion. It has more than 11,000 employees worldwide and provides diverse services for customers such as pharmaceutical and biotechnology enterprises, diagnostic laboratories, scientific research institutions and government agencies. The company is a member of the S&P 500 Index, and its customers are spread across more than 190 countries and regions around the world.